The Institute of Chemical Biology CDT expands its remit from 2019!

MicrofluidicsThe ICB has been successful in the renewal of its EPSRC CDT in Chemical Biology and is inviting proposals for 4-year PhD studentships.  Studentships awarded through this ICB CDT annual call will start in October 2019.

The aim of the CDT, one of the longest standing in the UK, is to train a new generation of PhD graduates (>80 over 5 years through an MRes + 3 Year PhD programme) in the art of multidisciplinary Chemical Biology research, giving them the opportunity to develop the next generation of molecular tools and technologies for making, measuring, modelling and manipulating molecular interactions in biological systems. The expanded remit of the CDT now also embraces multi-scale modelling (e.g. graph theory) and experimental approaches (micro-physiological environments) for studying molecular interactions and biological systems. Students on the programme will apply these advances to tackle key biological/biomedical problems and clinical/industrial challenges.

In addition, students will dovetail the development of these molecular tools and technologies with industry 4.0 platforms (e.g. automation, additive manufacturing / 3D printing, AI, machine learning, augmented reality, cloud computing, big data and analytics and Internet of Things) with a view to supporting the industrialization of the life sciences. In order to support this vision, students will benefit from bespoke training that will enable them to work seamlessly across the physical-life sciences and human-machine interfaces. This is a skill set which is in great demand from industry and addresses the future needs of employers in the pharmaceutical, biomedical, healthcare, personal care, biotech, agri-science and SME sectors.

In addition, students will be armed with an in-depth understanding of product development pipelines across a variety of sectors, acquired through first-hand experience of multi-disciplinary translational research and early stage commercialisation. This will enable them to become leaders of technology innovation and translation in the medical, pharma, life science, personal care and agri-science industries.